RK
Ranjay Kumar
About Ranjay Kumar
Data last updated:
Ranjay Kumar has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Medolis Pharmaceuticals Private Limited and Robust Engicon Private Limited. Formerly with 1 company, such as Robust Contractor Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Robust Engicon Private Limited U78100BR2023PTC062381 | Director | 07 Apr 2023 | 2023 | – | Active |
| Medolis Pharmaceuticals Private Limited U24230BR2019PTC043099 | Director | 22 Aug 2019 | 2019 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Robust Contractor Private Limited U70109BR2016PTC032077 | Director | 25 Jul 2022 | 2016 | ₹5.4 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranjay Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranjay Kumar
Ranjay Kumar has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Medolis Pharmaceuticals Private Limited and Robust Engicon Private Limited. Formerly with 1 company, such as Robust Contractor Private Limited. Engaged in General Business. Contributes to corporate operations.
Ranjay Kumar is associated with 2 companies as Director, including Robust Engicon Private Limited, Medolis Pharmaceuticals Private Limited.
Ranjay Kumar has expertise in General Business.
Ranjay Kumar has 7 years in corporate governance.
Ranjay Kumar currently holds positions at 2 companies: Robust Engicon Private Limited, Medolis Pharmaceuticals Private Limited.